RUNX3 and neoplasm: It is our future interest to develop mouse xenograft models by repeated in vivo passaging of these KGN/RUNX3 tumors in mice, in order to establish a KGN xenograft model with a faster tumor growth that would be suitable for therapeutic drug testing [43].